公式タイトルと情報はIP Exchange PlusとPremiumのユーザーのみが利用可能です。
テクノロジー A novel method for predicting patient response to neo-adjuvant chemoradiotherapy using label-free spectroscopic imaging. The technology uses biomarkers to predict response rates in a patient group, which typically has a responder rate of only 20%, in a high-cost treatment area. Proof of concept work has begun, and the technology will be further developed into a predicative software.
追加情報の詳細を見るにはIP Exchange PlusまたはIP Exchange Premiumアカウントにアップグレードする必要があります
